Views & Analysis What HCPs say about Roche's breast cancer drug The online conversations about breast cancer drug Kadcyla before it was approved by NICE.
Views & Analysis How healthcare professionals engage NICE online NICE is reaching out and engaging more via social media.
Views & Analysis What doctors say about Obamacare after US election Daniel Ghinn has been listening to the social media conversations of HCPs.
Views & Analysis What doctors say about EpiPen pricing The furore over Mylan’s ‘price gouging’ in relation to EpiPen in the US went global, thanks to social media.
Views & Analysis What doctors say about Theresa May’s reappointment of Jeremy... Reactions of healthcare professionals to Jeremy Hunt staying as Health Secretary.
Views & Analysis What doctors say about the EU referendum Daniel Ghinn tunes into the conversation around the EU referendum, which takes place on Thursday
News Akebia joins GSK in US market for oral CKD anaemia drugs The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS
Digital Sponsored Innovation as Strategy: Enabling life sciences of the future Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.